0.11
+27.73%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Baird Medical Investment Holdings
Its shares trade under the ticker BDMD. It has been listed since 21 October 2021. In the fiscal year to 31 December 2025, it reported revenue of $22.5m and a net loss of $27.3m. At that date it held total assets of $69.7m and shareholders' equity of $31.4m.
ExcelFin Acquisition Corp. operates as a blank check company. The company is headquartered in San Francisco, California. The company went IPO on 2021-10-21. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The firm intends to focus its search on a United States-based financial technology (FinTech) company engaged in business-to-business (B2B) software-as-a-service (SaaS) sector. The firm has not commenced any operations nor generated any revenues.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 21 Oct 2021
- Website
- excelfinacquisitioncorp.com ↗
- Head office
- 18/F, OVEST, SHEUNG WAN
- Incorporated in
- E9
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Emerging growth company
Leadership
Pay as last reported
- Ms. Jennifer HillIndependent Chairman of the Board
- Mr. Joe RaganChief Executive Officer, Chief Financial Officer, Director, since 2021
- Mr. Brian SunChief Operating Officer
- Mr. Goh PiaoDirector
- Mr. Gary MeltzerIndependent Director
- Mr. Neil WolfsonIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- ExcelFin Acquisition Corp. focuses on US-based FinTech B2B SaaS companies for business combinations.
- The company has a clear IPO date of 21 October 2021 for strategic planning.
- San Francisco headquarters provides access to a strong technology ecosystem.
Weaknesses
- ExcelFin has not selected any specific business combination target yet.
- The firm has not commenced any operations nor generated any revenues.
- No substantive discussions have been initiated with potential business targets.
Opportunities
- The US FinTech sector offers significant growth potential for B2B SaaS companies.
- San Francisco's tech hub supports innovative business combinations.
- ExcelFin can leverage the expanding FinTech market in the United States.
Threats
- The lack of selected targets delays potential business combinations.
- No revenue generation creates financial uncertainty for the company.
- Competition for FinTech targets may increase as the sector grows.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.